FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/10/2022
Voltar para busca
Dado oficial do USPTO
HEMACORE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
17/10/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10
Data de depósito
20/08/2020
Data de registro
24/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/05/2022
Última transação
24/05/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
RU
Examinador
SEVERSON, JUSTIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized tree design made up of four red branches and two grey branches with red leaves which cross and interweave and form a rounded crown. Below the design is the term "HEMACORE" with "HEMA" in red and "CORE" in grey. All on a white background.
Titulares e representantes
Titulares
Limited Liability Company "Hematological Corporation"
Representantes
Marina Sigareva Volpe Koenig
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Blood plasmafor the diagnosis of hemostasis; albuminous preparations for medical purposesfor the diagnosis and treatment of hemostatic disorders; biological preparations for medical purposesfor the diagnosis and treatment of hemostatic disorders; diagnostic preparations for medical purposes; enzyme preparations for medical purposesfor the diagnosis and treatment of hemostatic disorders; chemical reagents for medical or veterinary purposesfor the diagnosis and treatment of hemostatic disorders; saltssodium saltscalcium saltsfor medical purposesfor the diagnosis and treatment of hemostatic disorders; enzymes for medical purposesfor the diagnosis and treatment of hemostatic disorders
Classe 9
Testing apparatus not for medical purposesfor testing biological compounds; monitoring apparatusother than for medical purposesfor monitoring of spatiotemporal dynamics of biochemical reactions; apparatus and instruments for physicsthermostatspressure indicatorstemperature indicators; chemistry apparatus and instrumentsscattering metersspectrophotometers; measuring apparatusfor measuring of spatiotemporal dynamics of biochemical reactions; computer programsrecorded for scientificbiological and medical purposes for performing tests and processing data; computer softwarerecordedfor scientificbiological and medical purposes for performing tests and processing data
Classe 10
Testing apparatus for medical purposesfor the diagnosis of hemostasis; blood testing apparatusfor the diagnosis of hemostasis; diagnostic apparatus for medical purposesfor the diagnosis of hemostasis; medical apparatus and instrumentsfor the diagnosis and treatment of hemostasis disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/09/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
07/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/08/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
24/05/2022
GPNX
NOTIFICATION PROCESSED BY IB
13/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/03/2022
PUBO
PUBLISHED FOR OPPOSITION
08/03/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
16/02/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
16/02/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/07/2021
GNRT
NON-FINAL ACTION E-MAILED
30/07/2021
CNRT
NON-FINAL ACTION WRITTEN
30/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/06/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/06/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/06/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/06/2021
RFNT
REFUSAL PROCESSED BY IB
14/02/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/01/2021
RFRR
REFUSAL PROCESSED BY MPU
25/01/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/01/2021
CNRT
NON-FINAL ACTION WRITTEN
04/01/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/01/2021
DOCK
ASSIGNED TO EXAMINER
29/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/12/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEMACORE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.